Dager WE - Search Results

1

Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline.

Douketis JD, Spyropoulos AC, Murad MH, Arcelus JI, Dager WE, Dunn AS, Fargo RA, Levy JH, Samama CM, Shah SH, Sherwood MW, Tafur AJ, Tang LV, Moores LK. Douketis JD, et al. Among authors: dager we. Chest. 2022 Nov;162(5):e207-e243. doi: 10.1016/j.chest.2022.07.025. Epub 2022 Aug 11. Chest. 2022. PMID: 35964704

2

Executive Summary: Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline.

Douketis JD, Spyropoulos AC, Murad MH, Arcelus JI, Dager WE, Dunn AS, Fargo RA, Levy JH, Samama CM, Shah SH, Sherwood MW, Tafur AJ, Tang LV, Moores LK. Douketis JD, et al. Among authors: dager we. Chest. 2022 Nov;162(5):1127-1139. doi: 10.1016/j.chest.2022.08.004. Epub 2022 Aug 11. Chest. 2022. PMID: 35964703

3

Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia.

Tsu LV, Dager WE. Tsu LV, et al. Among authors: dager we. Ann Pharmacother. 2011 Oct;45(10):1185-92. doi: 10.1345/aph.1Q177. Epub 2011 Aug 31. Ann Pharmacother. 2011. PMID: 21881032

4

Bridging with Tirofiban during Oral Antiplatelet Interruption: A Single-Center Case Series Analysis Including Patients on Hemodialysis.

Walker EA, Dager WE. Walker EA, et al. Among authors: dager we. Pharmacotherapy. 2017 Aug;37(8):888-892. doi: 10.1002/phar.1956. Epub 2017 Jul 6. Pharmacotherapy. 2017. PMID: 28543216

5

Bivalirudin Dosing Requirements in Adult Patients on Extracorporeal Life Support With or Without Continuous Renal Replacement Therapy.

Walker EA, Roberts AJ, Louie EL, Dager WE. Walker EA, et al. Among authors: dager we. ASAIO J. 2019 Feb;65(2):134-138. doi: 10.1097/MAT.0000000000000780. ASAIO J. 2019. PMID: 29538017

6

Reversing the anticoagulation effects of dabigatran.

Dager WE, Banares L. Dager WE, et al. Hosp Pract (1995). 2017 Apr;45(2):29-38. doi: 10.1080/21548331.2017.1298389. Epub 2017 Mar 24. Hosp Pract (1995). 2017. PMID: 28335637 Review.

7

Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.

Chan A, Iannucci A, Dager WE. Chan A, et al. Among authors: dager we. Ann Pharmacother. 2007 Apr;41(4):635-41. doi: 10.1345/aph.1G714. Epub 2007 Mar 13. Ann Pharmacother. 2007. PMID: 17355999 Review.

8

Filtering Out Use of DOACs in Hemodialysis.

Dager WE, Lee JA. Dager WE, et al. Ann Pharmacother. 2017 Jun;51(6):511-513. doi: 10.1177/1060028016689265. Epub 2017 Jan 23. Ann Pharmacother. 2017. PMID: 28114796

9

Incomplete dabigatran reversal with idarucizumab.

Steele AP, Lee JA, Dager WE. Steele AP, et al. Among authors: dager we. Clin Toxicol (Phila). 2018 Mar;56(3):216-218. doi: 10.1080/15563650.2017.1349911. Epub 2017 Jul 13. Clin Toxicol (Phila). 2018. PMID: 28704111

10

Warfarin initiation and monitoring with clotting factors II, VII, and X.

Trask AS, Gosselin RC, Diaz JA, Dager WE. Trask AS, et al. Among authors: dager we. Ann Pharmacother. 2004 Feb;38(2):251-6. doi: 10.1345/aph.1D266. Epub 2003 Dec 30. Ann Pharmacother. 2004. PMID: 14742761

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page